Abstract:Clinical trials are essential to drug development but time-consuming, costly, and prone to failure. Accurate trial outcome prediction based on historical trial data promises better trial investment decisions and more trial success. Existing trial outcome prediction models were not designed to model the relations among similar trials, capture the progression of features and designs of similar trials, or address the skewness of trial data which causes inferior performance for less common trials. To fill the gap and provide accurate trial outcome prediction, we propose Sequential Predictive mOdeling of clinical Trial outcome (SPOT) that first identifies trial topics to cluster the multi-sourced trial data into relevant trial topics. It then generates trial embeddings and organizes them by topic and time to create clinical trial sequences. With the consideration of each trial sequence as a task, it uses a meta-learning strategy to achieve a point where the model can rapidly adapt to new tasks with minimal updates. In particular, the topic discovery module enables a deeper understanding of the underlying structure of the data, while sequential learning captures the evolution of trial designs and outcomes. This results in predictions that are not only more accurate but also more interpretable, taking into account the temporal patterns and unique characteristics of each trial topic. We demonstrate that SPOT wins over the prior methods by a significant margin on trial outcome benchmark data: with a 21.5\% lift on phase I, an 8.9\% lift on phase II, and a 5.5\% lift on phase III trials in the metric of the area under precision-recall curve (PR-AUC).

What problem does this paper attempt to address?

This paper attempts to solve several key problems in the prediction of clinical trial results: 1. **Lack of Modeling of the Relationship between Similar Trials**: Existing models fail to effectively capture the relationship between similar trials and the evolution of these trial designs and features. This leads to insufficient accuracy in predicting the results of new trials. 2. **Failure to Handle Data Imbalance Problems**: Clinical trial data usually has a serious class imbalance phenomenon, that is, the number of trials for certain subgroups or treatment methods is small and the success rates vary. This imbalance poses challenges to machine - learning models, especially for trials in the minority class, and existing methods are difficult to accurately predict their results. 3. **Failure to Alleviate the Heterogeneity of Trial Patterns**: Clinical trials for different diseases and stages may show different patterns. Existing work does not consider clustering trials into more homogeneous groups to reduce the impact of heterogeneity. To solve these problems, the author proposes a method named SPOT (Sequential Predictive Modeling of clinical Trial outcome). SPOT mainly achieves more accurate prediction of clinical trial results through the following three components: 1. **Topic Discovery**: SPOT uses the topic discovery module to cluster multi - source clinical trial data into related topics. In this way, it can better capture that trials within the same topic have more consistent patterns, thereby reducing noise and improving prediction accuracy. 2. **Sequential Modeling**: SPOT aggregates trials of the same topic into sequences according to timestamps and learns to model the temporal patterns of these sequences. This helps to extract the knowledge of the evolution of trial designs and their results, thereby enhancing the effect of trial embedding and result prediction. 3. **Meta - Learning**: To deal with the problem of data imbalance, SPOT regards each trial sequence as a task and adopts a meta - learning strategy, so that the model can quickly adapt to new tasks and achieve good generalization ability with only a small number of updates. Specifically, the workflow of SPOT is as follows: - **Input Data**: Original multi - source clinical trial data. - **Topic Discovery**: Use a pre - trained language model (such as Trial2Vec) to generate dense trial embeddings and assign trials to different topics through K - means clustering. - **Static Trial Embedding**: Encode the disease, treatment, and criteria for each trial to generate static embeddings. - **Sequential Trial Embedding**: Organize trial embeddings under the same topic according to the time sequence and capture time information through RNN. - **Meta - Learning Task Embedding**: Utilize meta - learning methods such as MAML to perform rapid adaptation based on task - specific parameters and global parameters. Through these steps, SPOT significantly improves the prediction performance in multiple trial phases (Phase I, II, III), especially with a significant improvement in the PR - AUC index, with an increase of 21.5% in Phase I, 8.9% in Phase II, and 5.5% in Phase III.

SPOT: Sequential Predictive Modeling of Clinical Trial Outcome with Meta-Learning

HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data

A Bayesian Platform Trial Design to Simultaneously Evaluate Multiple Drugs in Multiple Indications with Mixed Endpoints.

Optimal Marker-Strategy Clinical Trial Design to Detect Predictive Markers for Targeted Therapy

AI–Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes

A Bayesian Group Sequential Design for Randomized Biosimilar Clinical Trials with Adaptive Information Borrowing from Historical Data

A Survey of Artificial Intelligence Methods for Clinical Trial Outcome Prediction

Clinical Advancement Forecasting

Multimodal Clinical Trial Outcome Prediction with Large Language Models

Language Interaction Network for Clinical Trial Approval Estimation

A Bayesian Phase II Proof-of-concept Design for Clinical Trials with Longitudinal Endpoints.

Machine Learning Prediction of Clinical Trial Operational Efficiency

TrialGraph: Machine Intelligence Enabled Insight from Graph Modelling of Clinical Trials

Bayesian Group Sequential Enrichment Designs Based on Adaptive Regression of Response and Survival Time on Baseline Biomarkers.

Deep historical borrowing framework to prospectively and simultaneously synthesize control information in confirmatory clinical trials with multiple endpoints

Trial2Vec: Zero-Shot Clinical Trial Document Similarity Search using Self-Supervision

TRIALSCOPE: A Unifying Causal Framework for Scaling Real-World Evidence Generation with Biomedical Language Models

Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design

An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials

Prediction of clinical trials outcomes based on target choice and clinical trial design with multi‐modal artificial intelligence

PyTrial: Machine Learning Software and Benchmark for Clinical Trial Applications